Journal
MOLECULES
Volume 17, Issue 1, Pages 98-144Publisher
MDPI
DOI: 10.3390/molecules17010098
Keywords
biomedical optics; fluorescence diagnosis; phthalocyanines; NIR dyes; photodynamic therapy
Funding
- Swiss Science Foundation [205320-122144, 326030-117436, CR32I3-129987, 205321-126834, 310030-119938, K-32K1-116460]
- Council for Scientific and Industrial Research in South Africa
- [IZLSZ2-123011]
Ask authors/readers for more resources
The purpose of this review is to compile preclinical and clinical results on phthalocyanines (Pcs) as photosensitizers (PS) for Photodynamic Therapy (PDT) and contrast agents for fluorescence imaging. Indeed, Pcs are excellent candidates in these fields due to their strong absorbance in the NIR region and high chemical and photo-stability. In particular, this is mostly relevant for their in vivo activation in deeper tissular regions. However, most Pcs present two major limitations, i.e., a strong tendency to aggregate and a low water-solubility. In order to overcome these issues, both chemical tuning and pharmaceutical formulation combined with tumor targeting strategies were applied. These aspects will be developed in this review for the most extensively studied Pcs during the last 25 years, i.e., aluminium-, zinc- and silicon-based Pcs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available